Insider · CIK 0001813162
David R. Margrave
Files at LTRN (Lantern Pharma Inc.). First filing -, latest -.
In brief
David R. Margrave files SEC Form 4 as CFO at LTRN (Lantern Pharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David R. Margrave has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 22, 2025 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -78,300 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +78,300 | $0.00 | $0 | 78,300 | Sep 23, 2025 |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -26,100 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +26,100 | $0.00 | $0 | 26,100 | Sep 23, 2025 |
Questions about David R. Margrave
Answered from the filings on this page, as of the latest one.
Is David R. Margrave buying or selling?
David R. Margrave has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David R. Margrave's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David R. Margrave has 0.
Where does David R. Margrave file Form 4?
David R. Margrave has filed Form 4 at LTRN (Lantern Pharma Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.